Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Welcome to Signals

New Content ItemWelcome to Signals, the official open access journal of the International Cytokine & Interferon Society. Signals is a new publication encompassing all aspects of basic, clinical and translational research related to cytokines and will be publishing definitive reviews on cytokines, interleukins, chemokines and growth factors.

Signals is officially open for new submissions on all aspects of basic, clinical and translational research related to cytokines.

If you are a member of the International Cytokine & Interferon Society, the society will cover part or all of publication charges for your article. Please contact Joan Oefner - Managing Director, ICIS for more information.

Welcome to Signals, a new open-access journal owned by the International Cytokine & Interferon Society. The Editorial Board and I are excited to get this rolling after years in the planning with the goal of serving the scientific community. We are grateful to so many who contributed to this launch, and to our future authors and readers. Help us send Signals to the forefront of publications!

Scott K. Durum PhD, Editor-in-Chief

Signals is accepting submissions and will publish its first articles soon.

The International Cytokine & Interferon Society is a non-profit organization. It was established in 2011 from the fusion of two societies, The International Cytokine Society and The International Society for Cytokine and Interferon Research, both founded over 25 years ago. The Society conducts annual meetings around the world. Member scientists and clinicians are devoted to research in the fields of cytokine, interferon and chemokine cell biology, molecular biology, biochemistry and the clinical use of cytokines and their antagonists. Signals is the official journal and is owned by the Society.

Aims and scope

Signals is the official open access journal of the International Cytokine & Interferon Society. Committed to advancing the understanding of cytokine biology and its role in health and disease, the journal welcomes manuscripts on all aspects of basic, clinical and translational research related to cytokines. Topics include the discovery of novel cytokines, mechanism of action and signal pathways, dysregulation of cytokine signals and diseases, as well as the clinical application of cytokines and their inhibitors. With a rigorous peer review process and a global editorial board, Signals will give your research the high visibility desired within your community.  


Scott K Durum

Scott K Durum PhD, is a Senior Investigator in the National Cancer Institute, National Institutes of Health, USA. He previously founded, together with Sir Gordon Duff, the journal Cytokine, and served as an Editor-in-Chief. He was involved in founding the International Cytokine Society, a predecessor of the International Cytokine & Interferon Society, and has been involved in organizing their annual conferences. His research has largely centered on cytokine biology with a recent focus on the interleukin-7 pathway in health and disease.

Senior Editor

Cristina Bergamaschi

Cristina Bergamaschi PhD, is a Staff Scientist in the Human Retrovirus Pathogenesis Section in the Vaccine Branch at the National Cancer Institute. She is a molecular immunologist and vaccine biologist who has specialized in the development of immunomodulatory cytokine therapies for cancer treatment and improved vaccination strategies. Her research has largely centered on the biology, function and clinical application of interleukin-15.